Skip to main content
Terminated

Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum

By April 24, 2017No Comments

Condition

Carcinoma, Small Cell|Carcinoma, Non-Small-Cell Lung|Esophageal Neoplasms|Mesothelioma

Estimated Enrollment: 23

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Primary Purpose: Treatment

Study ID Numbers: 050010|05-C-0010

Study First Received: October 28, 2004

Last Updated: April 19, 2017

Estimated Primary Completion Date: May 20, 2013

 

Primary Outcome Measures:

Sponsors and Collaborators:

National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)

Website Link: https://ClinicalTrials.gov/show/NCT00094978

Leave a Reply